Benign Prostate Hyperplasia Clinical Trial
Official title:
Low Dose, Low Concentration Different Baricity Bupivacaine for Transuretral Prostatectomy.
Spinal anesthesia, is used during the transuretheral resection of the prostate.Low dose
hyperbaric local anesthetics have been used to enhance the resolution of the spinal block.
We compared the efficacy and duration of the spinal block with two different bupivacaine
baricities.
- Group I: low dose isobaric group
- GroupII: Low dose hyperbaric group
Patients undergoing TURP were randomly allocated into two groups.
- Group I: Received fentanyl 20 µgr (0.4ml),heavy bupivacaine 0.5% (1.5 ml)and normal
saline % 0.9 NaCl ( 1.1ml)
- Group II: Received fentanyl 20 µgr (0.4 ml), plain bupivacaine 0.5%(1.5 ml) normal
saline 0.9% NaCl (1.1 mL) in total bupivacaine 0.25% (3ml) intrathecally.
Onset and duration of the sensory block, the degree of the motor block, side - effects and
perioperative analgesic requirement assesed.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01942551 -
Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
|
Phase 1 | |
Completed |
NCT01436877 -
Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia
|
N/A | |
Completed |
NCT02822924 -
Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02390882 -
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
|
Phase 3 | |
Completed |
NCT02839122 -
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
|
Phase 1 | |
Completed |
NCT02332538 -
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH
|
N/A | |
Completed |
NCT01835860 -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
|
Phase 2/Phase 3 | |
Completed |
NCT01665586 -
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
|
N/A | |
Completed |
NCT02038868 -
A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
|
Phase 2 | |
Completed |
NCT02506465 -
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
|
N/A | |
Completed |
NCT01675895 -
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration
|
Phase 4 | |
Completed |
NCT02483819 -
Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients
|
N/A | |
Recruiting |
NCT02827578 -
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
|
Phase 3 | |
Completed |
NCT02352311 -
Safety and Pharmacokinetic Characteristics of DKF-313
|
Phase 1 | |
Completed |
NCT01494337 -
Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)
|
Phase 4 | |
Completed |
NCT01627522 -
Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate
|
Phase 2/Phase 3 | |
Completed |
NCT01952912 -
Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates
|
N/A | |
Active, not recruiting |
NCT01736033 -
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
|
Phase 4 | |
Recruiting |
NCT02021032 -
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
|
Phase 4 | |
Completed |
NCT00861588 -
Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia
|
N/A |